CCM>Free Info >News Update>2nd volume No.1>
Last Update: March 31st, 2001
Herbal Extracts & Traditional Chinese Medicines
Sample of Market Analysis
News Collection
 
Guangxia (Yinchuan) Signed RMB6 billion with Germany Company (Last update: 03/21/2001)
Guangxia (Yinchuan) Industry Co.Ltd. signed with Fidelity Trading GmBH of German a contract valued RMB6 billion for the next three years. Guangxia (Yinchuan) is specializing in herbal extraction. In the past two years, they have exported to Fidelity over RMB200 million of herb extract. According to the new contract, in the next three years, Guangxia (Yinchuan) will supply to Fidelity 157.5 MT of natural caffeine, 150MT of laurel peel oil, 150MT of laurel resin (containing oil), 160MT of ginger oil, 160MT of ginger resin (containing oil), tea (free of caffeine) 9,000MT. Guangxi (Yinchuan) aims to become the largest production base of herb extract in China. (Source: Security Times & cnchemicals.com)
 
Tea is Favorite Among Chinese (Last update: 03/13/2001)
Conclusion from Tea Industry Development Symposium shows that tea is still the most favorite beverage product in China. The average consumption of tea is 0.6kg per year per capita. In 1998, the production of tea is 665,000MT, 116,000 of which are famous brand in China. (Source: China Food News)
 
Lanzhou to Build Largest Medicinal Material Market in Northwest (Last update: 02/26/2001)
Lanzhou City plans to invest RMB426 million to enlarge the present medicinal material market which was built in 1996, one of the 17 state medicinal material trade market in China. After the enlargement, the market will cover 24,925 square meters. Last year the transaction volume in this market is RMB300 million. (Source: China TCM News)
 
Xinjiang to Plant Thousands Hectares of Herbs (Last update: 02/19/2001)
Xinjiang Yili government plans to allocate over thousand hectares of land to plant some characteristic herbs including licorice, ephedria. These herbs are strong items in Xinjiang area and have large demand due to the ever increasing market of herb extracts. (Source: China TCM News)
 
Ningxia Cultured Medlar Free of Seed (Last update: 02/19/2001)
A new technique to culture medlar without seed has been approved in Yinchuan, Ningxia province. Medlar is a characteristic herb in Ningxia province which is used to extract food supplement. By using this new technique, the output of medlar can be increased by 6.63%. (Source: China TCM News)
 
Astragalus Polyose Injection in Shanxi (Last update: 02/08/2001)
The astragalus polyose vein injection drug is born in Shanxi TCM Research Institute. It is the first vein injection drug of astragalus in the world. Shanxi TCM Research Institute began the research on this drug in 1994. Now this medicine has been approved as TCM New Medicine Type II. (Source: China Medicine News)
 
The Largest Production Base of Medicine in Northwest China (Last update: 02/08/2001)
Found in 1998, Xi'an Yiergao Keyuan Biochemical Co. Ltd. has set up six production bases in Chang'an, Baoji, Weinan, Ankang, Fengxiang and Gansu Heshui. Recently Xi'an Yiergao Keyuan has bought Gansu Xifeng Pharmaceutical Factory and becomes the largest medicine enterprises in northwest China. Xi'an Yiergao Keyuan mainly produce dioscin and dienolketone. Most of their products are exported to USA, Europe, Japan. Their products also supply to some domestic big pharmaceutical manufacturers like Zhejiang Pharm, Xihua Pharm. and Changzhou Pharm. It is reported that Xi'an Yiergao Keyuan will cooperate with some research units to develop Chuandilong (a kind of TCM) RES technology by clone technology. (Source: China Chemical Industry News)
 
Chemical Synthetic Ephedrine in Inner Mongolia (Last update: 02/08/2001)
China is the only country in the world to grow ephedra, a kind of natural herb to extract ephedrine. But because of the limitation of natural source, the Chinese ephedrine can not meet the demand from the international market. In 1997, Inner Mongolia Chifeng Pharmaceutical Factory broke through the production technology of ephedrine by chemical synthetic method. In the end of 1999, this technology got the approval from local government. Entering 2001, the commercial production of chemical synthetic ephedrine started in this factory. Chifeng Pharm. plans to set up 200MT/year production line of chemical synthetic ephedrine in the future. It is reported that the production cost of ephedrine by chemical method is only 60% of that of ephedrine from herb extraction. So far China becomes the third country in the world to develop successfully the chemical synthetic ephedrine, next to Germany and India. (Source: China Chemical Industry News)
 
Yangzijiang Pharm to Build Hailing Pharm (Last update: 01/15/2001)
Yangzijiang Pharmaceutical Group invest RMB120 million to build a new pharmaceutical factory, Hailing Pharmaceutical Co. Ltd. in Nanjing. The new factory covers 20 hectare. It is expected that the construction of the new factory will take 15 months. The new factory will focus on the marine pharmaceutical, TCM and biological pharmaceuticals. In the future, Yangzijiang will move its production base to Hailing Pharm. (Source: TCM Business News)
 
Large Valerian Source Found in Hubei (Last update: 01/08/2001)
Researchers in Hubei TCM College conclude, after 10 years' first hand investigation, that a large area of valerian is growing in northern area of Hubei. This conclusion overthrow the states from Japanese researchers that China has no valerian resource. (Source: Medicine Economic News)